Definition of Breast Cancer
By Brijesh GhelaniBreast cancer is according to the definition given by the National Cancer Institute, that form of cancer which occurs in the breast. This is a simple definition certainly and an accurate one, but there is more to it. For instance, what part of the breast does it attack? Does it attack one sex more than another? Let's delve into this just a little more and see if we can't get a clearer picture of just what this cancer is.
First of all, although we all tend to think of breast cancer as a women's disease it does indeed also attack men, although on a small enough scale as to be considered rare.
Breast cancer first of all attacks that part of the breast known as the ducts, those tubes located in the breast that carry the milk from the glands which manufacture milk, known as the lobules, to the nipples. This form of this cancer is known as ductal carcinoma and is the most common form of this cancer, being the type that occurs in eighty-five to ninety percent of the cases of this cancer diagnosed.
The next most common form of breast cancer is that which is called lobular carcinoma. This is the type that attacks that area in the lobe that ends in a large group of tiny bulbs that actually manufacture the milk. This kind of this cancer occurs in about eight percent of the cases of this cancer diagnosed.
It is important to note that breast cancer does not limit itself to just the area of the breasts but as it grows, it spreads to other parts of the body, and not just necessarily to those parts of the body to which the breasts are adjacent.
This cancer is one form of cancer for which a person can do a self examination. This sort of examination is important and should be done on a regular basis, on the average of at least once a month.
It is also important to have regular professional medical examinations for breast cancer and this included mammograms. Mammograms should be given on the average of once every four years for women from ages twenty to forty. After that, they should be given every year for women from forty on.
Breast cancer in all of its forms is a fast acting enemy. It is important that we act fast also. Don't wait for this cancer to make the first move.
First of all, although we all tend to think of breast cancer as a women's disease it does indeed also attack men, although on a small enough scale as to be considered rare.
Breast cancer first of all attacks that part of the breast known as the ducts, those tubes located in the breast that carry the milk from the glands which manufacture milk, known as the lobules, to the nipples. This form of this cancer is known as ductal carcinoma and is the most common form of this cancer, being the type that occurs in eighty-five to ninety percent of the cases of this cancer diagnosed.
The next most common form of breast cancer is that which is called lobular carcinoma. This is the type that attacks that area in the lobe that ends in a large group of tiny bulbs that actually manufacture the milk. This kind of this cancer occurs in about eight percent of the cases of this cancer diagnosed.
It is important to note that breast cancer does not limit itself to just the area of the breasts but as it grows, it spreads to other parts of the body, and not just necessarily to those parts of the body to which the breasts are adjacent.
This cancer is one form of cancer for which a person can do a self examination. This sort of examination is important and should be done on a regular basis, on the average of at least once a month.
It is also important to have regular professional medical examinations for breast cancer and this included mammograms. Mammograms should be given on the average of once every four years for women from ages twenty to forty. After that, they should be given every year for women from forty on.
Breast cancer in all of its forms is a fast acting enemy. It is important that we act fast also. Don't wait for this cancer to make the first move.
For more information about Definition of breast cancer please visit our site http://www.howcurecancer.com.
Article Source: http://EzineArticles.com/?expert=Brijesh_Ghelani
Symptoms of Breast Cancer in Women
By Brijesh Ghelani
We often are made aware of the importance of regular periodic breast examinations, looking for lumps which may be symptoms of breast cancer, but how often do we hear about the other equally important signs which may also be symptoms of cancer? Yes, they do exist and should be as much a part of those regular periodic breast examinations as are the lumps for which we look and hope not to find.
The first is when a breast feels unusually warm or hot to the touch. This may well be a sign of what is called inflammatory breast cancer. While this is a rare type of cancer, it does still occur and is known to be a very aggressive type of cancer so it is important to be aware of its symptoms and to act immediately if there seem to be any possible signs of it.
The second sign that we don't often here about is when an ordinary looking nipple that suddenly takes on an unordinary look is also another sign of possible cancer. If a nipple becomes flat, inverted or distorted in any way it is important to have it checked immediately.
The third sign is what I term the super itch. Again this is something that should be checked immediately. An itchy breast or nipple is again a little known but very real sign of a possible cancer.
Fourthly, the skin of the breast and also around the breast takes on a, for lack of a better term, dimpled appearance, looking much like a piece of the skin of an orange.
Fifth, a consistently swollen breast. Many women look at an increase in breast size as a blessing. This isn't necessarily so. If the size of a breast increases, there has to be a reason and it is important to have it checked out in case this reason is cancer.
Sixth, the breast becomes red and blotchy. Also it may develop a rash. This is another sign of a possibility of inflammatory breast cancer and should be checked out as soon as possible.
All of these signs are as valid as the lumps when it comes to possible signs of cancer and should be watched for and if they should arise, they should be examined and tested by a medical professional as soon as possible. Cancer doesn't wait once it has started. It is quick to claim its territory and to aggressively spread to other parts of the body. Cancer doesn't wait and neither should we.
The first is when a breast feels unusually warm or hot to the touch. This may well be a sign of what is called inflammatory breast cancer. While this is a rare type of cancer, it does still occur and is known to be a very aggressive type of cancer so it is important to be aware of its symptoms and to act immediately if there seem to be any possible signs of it.
The second sign that we don't often here about is when an ordinary looking nipple that suddenly takes on an unordinary look is also another sign of possible cancer. If a nipple becomes flat, inverted or distorted in any way it is important to have it checked immediately.
The third sign is what I term the super itch. Again this is something that should be checked immediately. An itchy breast or nipple is again a little known but very real sign of a possible cancer.
Fourthly, the skin of the breast and also around the breast takes on a, for lack of a better term, dimpled appearance, looking much like a piece of the skin of an orange.
Fifth, a consistently swollen breast. Many women look at an increase in breast size as a blessing. This isn't necessarily so. If the size of a breast increases, there has to be a reason and it is important to have it checked out in case this reason is cancer.
Sixth, the breast becomes red and blotchy. Also it may develop a rash. This is another sign of a possibility of inflammatory breast cancer and should be checked out as soon as possible.
All of these signs are as valid as the lumps when it comes to possible signs of cancer and should be watched for and if they should arise, they should be examined and tested by a medical professional as soon as possible. Cancer doesn't wait once it has started. It is quick to claim its territory and to aggressively spread to other parts of the body. Cancer doesn't wait and neither should we.
For more information about Symptoms of breast cancer please visit our site http://www.howcurecancer.com.
Article Source: http://EzineArticles.com/?expert=Brijesh_Ghelani
Information About Breast Cancer Treatment
By Brijesh GhelaniBreast Cancer is the cancer that develops in the breast tissues mostly in the inner lining of milk ducts or in the lobules which supply milk to the ducts. Depending on the place of origination, they are known as ductal carcinoma, if originated in the milk ducts or lobular carcinoma when originated in the lobules. Breast cancers are also classified as hormone-positive or a hormone-negative cancer which is decided based on their sensitivity to hormones like progesterone and estrogen.
The options available for breast cancer treatment depend on the type of breast cancer and the staging results. Staging is the process in which the disease spread and its progressive extend is determined. Though it is the most common non-skin type of cancer in women and is considered one of the fatal types of cancer, there are many advanced breast cancer treatment options which can help cure this disease if detected early.
Breast Cancer Treatment Plan
Once the cancer has been diagnosed, the doctors evaluate the pathology report and form a plan that would suit the type of cancer and the stage to which the disease has progressed. Treatment modes aim at reducing the spread of the disease, destruction of the diseased cells and reduction of chances for re-occurrence in future. The doctors would choose a single or a set of treatment options based on the patient's medical conditions which they may evaluate periodically.
Types of Breast cancer treatment methods
The treatments available are in general classified as standard methods and clinical trial methods. Standard methods are those that are currently practised for the cure of breast cancer while clinical trials are those that are currently being tested for more efficient results. The standard methods of breast cancer treatment include surgery, hormone therapy, chemotherapy, radiation treatments and targeted therapy.
Surgical method of Breast Cancer Treatment
Surgery is one potential option for removing the cancerous cells from the body. The entire breast or a partial portion of the breast is removed depending on the level of spread and the stage to which the disease has progressed. Based on the level of operation that is required to remove the cancerous cells, the surgeries are differentiated into three types as below.
* Breast-conserving Surgery - This is an operation where only the portion of the breast that contains the cancer is removed and not the breast itself. If the surgery requires removal of just the tumor in the breast and a little amount of tissue, it is known as Lumpectomy or is known as Partial mastectomy if it includes removal of partial amount of the breast along with a considerable amount of normal tissues. These kinds of surgeries may also include removal of lymph nodes under the arm which are used for the purpose of biopsy. Such dissection done either along with the surgery or after it is known as lymph node dissection.
* Total Mastectomy - This kind of surgery targets on removing the whole breast which is infected with the cancerous cells. This also requires removal of lymph nodes for the purpose of biopsy.
* Modified radical Mastectomy - This is the surgery that removes extensive portions to get rid of the cancerous cells. The complete breast affected by cancer along with certain lymph nodes under the arm and the chest muscle lining is removed by this process of surgery. In certain cases, even part of the chest wall muscles that are affected are removed by this surgery.
* Radical Mastectomy - This surgery removes the complete breast, chest wall muscles and all the lymph nodes under the arm. This kind of surgery for breast cancer treatment is also known as Halsted radical mastectomy.
These surgeries can also be followed by other modes of breast cancer treatment methods like chemotherapy, hormone therapy or radiation therapy to kill any presence of cancer cells. Such kinds of treatment that helps in prevention of cancer re-occurrence is known as adjuvant therapy. Some patients can also consider the option of breast implants to rebuild the removed breast shape after a mastectomy.
Chemotherapy
This kind of treatment helps in killing the cancerous cells or prevents them from growing by means of internal administration of drugs. The way of drug administration can be either through the blood stream that spreads throughout the body which is known as systematic chemotherapy or is placed directly in the cerebrospinal fluid or any specific organ which is known as regional chemotherapy.
Hormone Therapy
This kind of breast cancer treatment includes the introduction of substances that negate the effect of hormones which induce cancerous growth. Estrogen has been known to induce the growth of breast cancer in certain cases. One of the treatment methods includes prevention of ovaries from secreting the hormone estrogen and such a method is known as ovarian ablation. The hormonal therapy includes the usage of aromatase inhibitor which decreases the estrogen secretion in the body. Aromatase inhibitors are given for hormone-dependent breast cancer patients who are in postmenopausal stage while tamoxifen is used in cases of metastatic breast cancer. Aromatase inhibitors are also in general used as a means of adjuvant therapy after continued use of tamoxifen for two years or more.
Radiation Therapy
High energy x-rays are in general used as an alternative for drugs to kill the cancer cells and prevent them from growing.
Targeted Therapy
Another type of treatment that helps in destroying the cancer cells without any harm to the normal cells is called targeted therapy. The targeted therapies used in breast cancer treatment are in general of two types, Monoclonal antibodies and Tyrosine kinase inhibitors.
* Monoclonal Antibodies - These kinds of substances are antibodies that are made from a single type of immune system cell which has the potential to identify and destroy cancer cells. They are also sometimes used to carry toxins or drugs to the cancer cells to bring in effective destruction of the cells. Trastuzumab is a monoclonal antibody that is used in treating patients of breast cancer. This method can be clubbed along with chemotherapy as a means of adjuvant therapy.
* Tyrosine Kinase inhibitors - These drugs block signals that are needed for tumor growth and are in general used in combination with other anti-cancer drugs. Lapatjnib is one such inhibitor which helps block the HER2 protein inside the tumor cells and is used effectively for treatment of HER2- positive breast cancer patients.
The options available for breast cancer treatment depend on the type of breast cancer and the staging results. Staging is the process in which the disease spread and its progressive extend is determined. Though it is the most common non-skin type of cancer in women and is considered one of the fatal types of cancer, there are many advanced breast cancer treatment options which can help cure this disease if detected early.
Breast Cancer Treatment Plan
Once the cancer has been diagnosed, the doctors evaluate the pathology report and form a plan that would suit the type of cancer and the stage to which the disease has progressed. Treatment modes aim at reducing the spread of the disease, destruction of the diseased cells and reduction of chances for re-occurrence in future. The doctors would choose a single or a set of treatment options based on the patient's medical conditions which they may evaluate periodically.
Types of Breast cancer treatment methods
The treatments available are in general classified as standard methods and clinical trial methods. Standard methods are those that are currently practised for the cure of breast cancer while clinical trials are those that are currently being tested for more efficient results. The standard methods of breast cancer treatment include surgery, hormone therapy, chemotherapy, radiation treatments and targeted therapy.
Surgical method of Breast Cancer Treatment
Surgery is one potential option for removing the cancerous cells from the body. The entire breast or a partial portion of the breast is removed depending on the level of spread and the stage to which the disease has progressed. Based on the level of operation that is required to remove the cancerous cells, the surgeries are differentiated into three types as below.
* Breast-conserving Surgery - This is an operation where only the portion of the breast that contains the cancer is removed and not the breast itself. If the surgery requires removal of just the tumor in the breast and a little amount of tissue, it is known as Lumpectomy or is known as Partial mastectomy if it includes removal of partial amount of the breast along with a considerable amount of normal tissues. These kinds of surgeries may also include removal of lymph nodes under the arm which are used for the purpose of biopsy. Such dissection done either along with the surgery or after it is known as lymph node dissection.
* Total Mastectomy - This kind of surgery targets on removing the whole breast which is infected with the cancerous cells. This also requires removal of lymph nodes for the purpose of biopsy.
* Modified radical Mastectomy - This is the surgery that removes extensive portions to get rid of the cancerous cells. The complete breast affected by cancer along with certain lymph nodes under the arm and the chest muscle lining is removed by this process of surgery. In certain cases, even part of the chest wall muscles that are affected are removed by this surgery.
* Radical Mastectomy - This surgery removes the complete breast, chest wall muscles and all the lymph nodes under the arm. This kind of surgery for breast cancer treatment is also known as Halsted radical mastectomy.
These surgeries can also be followed by other modes of breast cancer treatment methods like chemotherapy, hormone therapy or radiation therapy to kill any presence of cancer cells. Such kinds of treatment that helps in prevention of cancer re-occurrence is known as adjuvant therapy. Some patients can also consider the option of breast implants to rebuild the removed breast shape after a mastectomy.
Chemotherapy
This kind of treatment helps in killing the cancerous cells or prevents them from growing by means of internal administration of drugs. The way of drug administration can be either through the blood stream that spreads throughout the body which is known as systematic chemotherapy or is placed directly in the cerebrospinal fluid or any specific organ which is known as regional chemotherapy.
Hormone Therapy
This kind of breast cancer treatment includes the introduction of substances that negate the effect of hormones which induce cancerous growth. Estrogen has been known to induce the growth of breast cancer in certain cases. One of the treatment methods includes prevention of ovaries from secreting the hormone estrogen and such a method is known as ovarian ablation. The hormonal therapy includes the usage of aromatase inhibitor which decreases the estrogen secretion in the body. Aromatase inhibitors are given for hormone-dependent breast cancer patients who are in postmenopausal stage while tamoxifen is used in cases of metastatic breast cancer. Aromatase inhibitors are also in general used as a means of adjuvant therapy after continued use of tamoxifen for two years or more.
Radiation Therapy
High energy x-rays are in general used as an alternative for drugs to kill the cancer cells and prevent them from growing.
Targeted Therapy
Another type of treatment that helps in destroying the cancer cells without any harm to the normal cells is called targeted therapy. The targeted therapies used in breast cancer treatment are in general of two types, Monoclonal antibodies and Tyrosine kinase inhibitors.
* Monoclonal Antibodies - These kinds of substances are antibodies that are made from a single type of immune system cell which has the potential to identify and destroy cancer cells. They are also sometimes used to carry toxins or drugs to the cancer cells to bring in effective destruction of the cells. Trastuzumab is a monoclonal antibody that is used in treating patients of breast cancer. This method can be clubbed along with chemotherapy as a means of adjuvant therapy.
* Tyrosine Kinase inhibitors - These drugs block signals that are needed for tumor growth and are in general used in combination with other anti-cancer drugs. Lapatjnib is one such inhibitor which helps block the HER2 protein inside the tumor cells and is used effectively for treatment of HER2- positive breast cancer patients.
For more information about Breast Cancer Treatment please visit our site http://www.howcurecancer.com.
Article Source: http://EzineArticles.com/?expert=Brijesh_Ghelani
Advanced Breast Cancer - Tamoxifen
Tamoxifen has been used to treat advanced breast cancer for 30 years and has been the first-line endocrine therapy of choice for much of this period. It is well tolerated and inexpensive, and serious side effects are uncommon. Survival rates are equivalent to those from chemotherapy, and although initial response rates are lower, it offers a superior quality of life in initial responders. Tamoxifen should not be displaced as a key therapy for advanced breast cancer without substantial and convincing data from large randomized trials. Response rates depend on patient selection and are higher for patients with estrogen-responsive tumors.
Tamoxifen alone has efficacy similar to that of estrogens or progestins when used singly or in combination, but it is better tolerated than most alternative endocrine therapies. In premenopausal patients there is good evidence that the combination of tamoxifen and a luteinizing hormone-releasing hormone (LHRH) analogue is superior to either single agent alone. This benefit of combination endocrine therapy with tamoxifen will not necessarily be translated to postmenopausal patients. Recently, third-generation aromatase inhibitors have been compared with tamoxifen in postmenopausal patients with advanced breast cancer and have been shown to have possibly superior efficacy, with reduced side effects.
This opens up new, potentially beneficial strategies using combined endocrine therapies-concurrently and in sequence in both pre- and postmenopausal patients. Given the sequential benefits demonstrated for tamoxifen from advanced to in situ disease and prevention for over 30 years, it seems very likely that aromatase inhibitors will be shown to be effective in all types of endocrine-responsive breast cancer. Future clinical trials testing endocrine therapies in advanced breast cancer should be large, have similar defined populations and biological endpoints, and involve intergroup collaborations similar to those established for adjuvant trials. This is essential to avoid taking another 30 years to evaluate newer endocrine therapies.
Tamoxifen alone has efficacy similar to that of estrogens or progestins when used singly or in combination, but it is better tolerated than most alternative endocrine therapies. In premenopausal patients there is good evidence that the combination of tamoxifen and a luteinizing hormone-releasing hormone (LHRH) analogue is superior to either single agent alone. This benefit of combination endocrine therapy with tamoxifen will not necessarily be translated to postmenopausal patients. Recently, third-generation aromatase inhibitors have been compared with tamoxifen in postmenopausal patients with advanced breast cancer and have been shown to have possibly superior efficacy, with reduced side effects.
This opens up new, potentially beneficial strategies using combined endocrine therapies-concurrently and in sequence in both pre- and postmenopausal patients. Given the sequential benefits demonstrated for tamoxifen from advanced to in situ disease and prevention for over 30 years, it seems very likely that aromatase inhibitors will be shown to be effective in all types of endocrine-responsive breast cancer. Future clinical trials testing endocrine therapies in advanced breast cancer should be large, have similar defined populations and biological endpoints, and involve intergroup collaborations similar to those established for adjuvant trials. This is essential to avoid taking another 30 years to evaluate newer endocrine therapies.
Be aware of cancer. Participate in cancer walk to prevent cancer. Article Source: http://EzineArticles.com/?expert=William_R_Miller |
Treatment of Advanced Breast Cancer
Since the introduction of aminoglutethimide, the first aromatase inhibitor, for breast cancer treatment 30 years ago, these drugs have achieved increasing importance in the therapy of advanced breast cancer and are currently being evaluated in the adjuvant setting. The third-generation aromatase inhibitors and inactivators-principally anastrozole, letrozole, and exemestane-all exhibit potent biochemical efficacy, with 97-99% aromatase inhibition. In addition, these drugs are well tolerated, and clinical studies have revealed their superiority over conventional drugs (aminoglutethimide and megestrol acetate) in second-line therapy.
The results for these agents as a first-line treatment are more varied. Letrozole has been found to be superior to tamoxifen with respect to overall response rate as well as time to progression (TTP).
This aromatase inhibitor has, furthermore, been shown to be superior to tamoxifen for particular subgroups, such as for estrogen (ER)/progesterone receptor (PgR)-positive tumors and in patients not exposed to adjuvant endocrine therapy.
Anastrozole, on the other hand, has been found to be of equivalent efficacy to tamoxifen in clinical trials, but it is not clear whether it provides superiority. Preliminary results from an ongoing study evaluating exemestane are encouraging, but so far the number of patients is too small to draw any conclusion. The early results with these novel compounds support the hypothesis that their clinical efficacy is related to the degree of estrogen suppression they produce. The observation from in vitro studies that tumor cells may adapt to low estrogen concentrations indicates that therapeutic advantage may be found in using more potent estrogen-suppressing drugs. The observed lack of cross-resistance between aromatase inhibitors and inactivators (formerly called steroidal aromatase inhibitors) represents a key subject for further investigation.
Aromatase inhibitors suppress estrogen synthesis by blocking the final step in the synthetic pathway aromatization of an androgen to an estrogen. Although the aromatase enzyme found in the ovaries and peripheral tissue (the site of E1 synthesis in postmenopausal women) is the same, the early results using aminoglutethimide found that ovarian estrogen blockade was overruled by gonadotrophin secretion. This was also found for the second-generation aromatase inactivator formestane; therefore, it has become accepted that these drugs are unsuitable for treatment of premenopausal women.
This still remains to be proven for the third-generation inhibitors/inactivators; considering their much greater potency, the possibility exists they will also block the ovarian aromatase activity.
The pathways of estrogen synthesis in postmenopausal women have been described and are not given in detail here. Briefly, it should be recalled that circulating androgens (mainly androstenedione), synthesized in the adrenal glands and (to a lesser extent) in the ovaries, are converted into estrogens in different peripheral tissues like muscle, connective tissue, skin, and liver. Estrogen synthesis also occurs in normal breast tissue as well as in breast tumors. It is interesting that in contrast to what is seen in premenopausal individuals, tissue estradiol concentrations are much higher than plasma levels in postmenopausal women. Whether this is related to local synthesis, active uptake mechanisms, or both is currently unknown.
The results for these agents as a first-line treatment are more varied. Letrozole has been found to be superior to tamoxifen with respect to overall response rate as well as time to progression (TTP).
This aromatase inhibitor has, furthermore, been shown to be superior to tamoxifen for particular subgroups, such as for estrogen (ER)/progesterone receptor (PgR)-positive tumors and in patients not exposed to adjuvant endocrine therapy.
Anastrozole, on the other hand, has been found to be of equivalent efficacy to tamoxifen in clinical trials, but it is not clear whether it provides superiority. Preliminary results from an ongoing study evaluating exemestane are encouraging, but so far the number of patients is too small to draw any conclusion. The early results with these novel compounds support the hypothesis that their clinical efficacy is related to the degree of estrogen suppression they produce. The observation from in vitro studies that tumor cells may adapt to low estrogen concentrations indicates that therapeutic advantage may be found in using more potent estrogen-suppressing drugs. The observed lack of cross-resistance between aromatase inhibitors and inactivators (formerly called steroidal aromatase inhibitors) represents a key subject for further investigation.
Aromatase inhibitors suppress estrogen synthesis by blocking the final step in the synthetic pathway aromatization of an androgen to an estrogen. Although the aromatase enzyme found in the ovaries and peripheral tissue (the site of E1 synthesis in postmenopausal women) is the same, the early results using aminoglutethimide found that ovarian estrogen blockade was overruled by gonadotrophin secretion. This was also found for the second-generation aromatase inactivator formestane; therefore, it has become accepted that these drugs are unsuitable for treatment of premenopausal women.
This still remains to be proven for the third-generation inhibitors/inactivators; considering their much greater potency, the possibility exists they will also block the ovarian aromatase activity.
The pathways of estrogen synthesis in postmenopausal women have been described and are not given in detail here. Briefly, it should be recalled that circulating androgens (mainly androstenedione), synthesized in the adrenal glands and (to a lesser extent) in the ovaries, are converted into estrogens in different peripheral tissues like muscle, connective tissue, skin, and liver. Estrogen synthesis also occurs in normal breast tissue as well as in breast tumors. It is interesting that in contrast to what is seen in premenopausal individuals, tissue estradiol concentrations are much higher than plasma levels in postmenopausal women. Whether this is related to local synthesis, active uptake mechanisms, or both is currently unknown.
More information, visit cancer and cancer survival rates Article Source: http://EzineArticles.com/?expert=William_R_Miller |
Basic Facts of Breast Cancer
Breast cancer is a disease that affects women and is also the second leading cause of death. According to the American Medical Association and American Cancer Society, cancer of the breast is the most common disease than women. It usually does not affect women until they reach age 20.
Each year, millions of women are diagnosed with breast cancer.It is due to the amount and frequency of screening. As we age, women, increase cancer screening visits.
Most women go through a procedure when they visit their doctor they have a mammogram. Mammography is used to determine if cancer is present.
With all these discussions about cancer of the breast, the question is what is cancer of the breast. Breast cancer is when abnormal cells that have mutated in some way to the point that it is not normal. The next question is why women get it?
There are many causes of cancer of the breast. In some women, cancer of the breast appears to form if your menstrual cycle begins early. The average age of first menstrual period is about 12 years. But for those who start earlier, run a risk for breast cancer during her lifetime, especially before reaching 30.
Another reason is the late menopause. If a woman has menopause after age 50, causes the system to have side effects. hormones change, too late.
Having a diet too rich in saturated fats can cause cancer of the breast. Diet, which contains unsaturated fats, like canola and olive oil did not appear to cause or increase the chances of cancer of the breast.
Many types of breast cancers are hereditary. If the family has had cancer of the breast, it is very likely to move for posterity. So if you had a great-grandmother, grandmother, mother, sister or cousin who had breast cancer, there is a chance you could get it to.
Women taking estrogen replacement therapy have a chance to get breast cancer. This is true whether the treatment was extended to 10 years. It is clear that breast cancer is a serious disease that can not be taken lightly. Women should never refuse to take the tests, especially when they reach age 20.
Each year, millions of women are diagnosed with breast cancer.It is due to the amount and frequency of screening. As we age, women, increase cancer screening visits.
Most women go through a procedure when they visit their doctor they have a mammogram. Mammography is used to determine if cancer is present.
With all these discussions about cancer of the breast, the question is what is cancer of the breast. Breast cancer is when abnormal cells that have mutated in some way to the point that it is not normal. The next question is why women get it?
There are many causes of cancer of the breast. In some women, cancer of the breast appears to form if your menstrual cycle begins early. The average age of first menstrual period is about 12 years. But for those who start earlier, run a risk for breast cancer during her lifetime, especially before reaching 30.
Another reason is the late menopause. If a woman has menopause after age 50, causes the system to have side effects. hormones change, too late.
Having a diet too rich in saturated fats can cause cancer of the breast. Diet, which contains unsaturated fats, like canola and olive oil did not appear to cause or increase the chances of cancer of the breast.
Many types of breast cancers are hereditary. If the family has had cancer of the breast, it is very likely to move for posterity. So if you had a great-grandmother, grandmother, mother, sister or cousin who had breast cancer, there is a chance you could get it to.
Women taking estrogen replacement therapy have a chance to get breast cancer. This is true whether the treatment was extended to 10 years. It is clear that breast cancer is a serious disease that can not be taken lightly. Women should never refuse to take the tests, especially when they reach age 20.
So my question is do you have cancer of the breast and want to get rid of it? Would you like to prevent it from developing, if you do not have it now?
If you want to have a healthy body right now, then take action now, by obtaining your copy of my guide.click here http://bit.ly/iaE6Tu
If you want to have a healthy body right now, then take action now, by obtaining your copy of my guide.click here http://bit.ly/iaE6Tu
Article Source: http://EzineArticles.com/?expert=Frank_D_Dimartin
